CytoSorbents, Inc
Nasdaq CTSO · Princeton, NJ
Works in Cardiovascular · GI & liver · Hematology · Infectious disease · Musculoskeletal · Psychiatry · Renal & urogenital · Respiratory · Women's health
CytoSorbents, Inc is a clinical trial sponsor based in Princeton, NJ, listed as Nasdaq CTSO. It has 2 active clinical trials with 4,000 planned participants, across 9 therapeutic areas. Since 2021 it has completed 3 trials and stopped 4 early.
Trial track record · since 2021
Financials · Nasdaq CTSO
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about CytoSorbents, Inc
CytoSorbents, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 4,000 planned participants, in Cardiovascular, GI & liver, Hematology, Infectious disease and other areas. Since 2021 it has completed 3 trials and stopped 4 early.
CytoSorbents, Inc is based in Princeton, NJ and is listed as Nasdaq CTSO. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with CytoSorbents, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-09-11.
Approve Suite is not affiliated with CytoSorbents, Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.